Medidata Solutions Inc (MDSO) is Reiterated by Needham to Buy, Raises Price Target to $ 57

Medidata Solutions Inc (MDSO) was Reiterated by Needham to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 57 from a previous price target of $45 . Needham advised their investors in a research report released on Apr 22, 2016.

Many Wall Street Analysts have commented on Medidata Solutions Inc. Company shares were Reiterated by Topeka Capital Markets on Apr 22, 2016 to “Buy”, Firm has raised the Price Target to $ 51 from a previous price target of $44 .Company shares were Reiterated by Topeka Capital Markets on Apr 5, 2016 to “Buy”, Firm has raised the Price Target to $ 44 from a previous price target of $42 .Shares were Reiterated by Deutsche Bank on Feb 11, 2016 to “Buy” and Lowered the Price Target to $ 41 from a previous price target of $53 .

On the company’s financial health, Medidata Solutions Inc reported $0.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $0.18. The company had revenue of $104.20 million for the quarter, compared to analysts expectations of $103.27 million. The company’s revenue was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.17 EPS.

Medidata Solutions Inc opened for trading at $45 and hit $46.39 on the upside on Wednesday, eventually ending the session at $46.17, with a gain of 11.15% or 4.63 points. The heightened volatility saw the trading volume jump to 9,95,122 shares. Company has a market cap of $2,602 M.

In a different news, on Feb 17, 2016, Lee Shapiro (director) purchased 1,500 shares at $33.45 per share price. According to the SEC, on Jul 22, 2015, Steven Isaac Hirschfeld (Chief Commercial Officer) sold 10,201 shares at $60.00 per share price. On Jun 1, 2015, Robert Taylor (director) sold 5,048 shares at $56.81 per share price, according to the Form-4 filing with the securities and exchange commission.

Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Company’s solutions are Medidata Rave an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS a clinical trial management solution; Medidata Designer a protocol design tool; Medidata Insights which offer clinical business analytics and metrics; Medidata Balance a randomization and trial supply management solution; Medidata Patient Cloud an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor an analytics tool; Medidata SQM a set of cloud-based site quality management dashboards; Medidata Coder a medical coding and synonym management solution; Medidata Safety Gateway which collects and transmits events and related data from the EDC system and Medidata Targeted SDV which implements risk-based monitoring strategies.

Medidata Solutions Inc

Leave a Reply

Medidata Solutions Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medidata Solutions Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.